• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Oral Contraceptive Users and Depressive Symptoms

Oral Contraceptive Users and Depressive Symptoms

October 30, 2020
Kristen Gardner, PharmD.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Kristen Gardner, PharmD. Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: de Wit AE et al, JAMA Psychiatry 2019;77(1):52–59

Since the dawn of their widespread use in the 1960s, we’ve worried about the impact of oral contraceptives (OCP) on mood. But the research to date has been inconsistent, with studies reporting negative, positive, or no effects on mood. Heterogeneity in study population and design may underlie these discrepancies. This new study uses a longitudinal design to provide some very useful data on the connection between OCP and various depressive symptoms.

The study used data from the Dutch population survey TRAILS (Tracking Adolescents’ Individual Lives Survey), which included 1,010 females aged 16–25 years who had 1–4 assessments of OCP use and depressive symptoms. The researchers used the affective problems scale of the Youth and Adult Self-Report to measure depressive symptoms. Follow-up assessments were conducted at ages 16, 19, 22, and 25 years.

In young women (aged 19, 22, and 25 years), there was no difference in depressive symptoms between OCP users and non-users. But adolescent OCP users (aged 16 years) reported nearly twice as much crying, over 1.5 times more hypersomnia, and about 1.5 times more eating problems compared to non-users even after adjustment for age, ethnicity (Dutch vs non-Dutch), and socioeconomic status. The association between depressive symptoms and adolescent OCP users was weaker, but still present, after adjustment for virginity, acne, menstrual-related pain, stressful event exposure, and depressive symptom scores before OCP use.

This study was notable for its prospective design, 9-year follow-up across multiple time points, and use of a validated questionnaire for depressive symptomatology. Still, we don’t know what indications were cited for these patients (birth control, menstrual irregularities, acne, etc), nor which OCPs were used (eg, progesterone vs mixed progesterone-estrogen). Also, we don’t know if these findings generalize to a non-Dutch population.

CCPR’s Take
We would not merely avoid OCP to reduce depression risk. The strength and mediators of the association between OCP use and depressive symptoms in adolescents remain unclear. OCP use might also be a marker for sexual behavior associated with other psychosocial concerns. OCPs help with dysmenorrhea, premenstrual syndrome, and prevention of unintended pregnancies, and the authors note that OCP use is safer than pregnancy and postpartum depression. Moreover, SSRIs may be helpful or may exacerbate pre- and perimenstrual mood problems. It’s a complicated topic—with each patient we will learn something new.
Child Psychiatry
KEYWORDS adolescents depression oral-contraceptives teens
    Kristen Gardner, PharmD.

    Olanzapine for Anorexia Nervosa

    More from this author
    www.thecarlatreport.com
    Issue Date: October 30, 2020
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Mood Disorders in Children and Adolescents, CCPR, Oct/Nov/Dec 2020
    Note From the Editor-in-Chief
    Our Role in Community Disasters
    Duty to Warn? Debating Antidepressant Suicidality
    Managing Video Gaming in Children and Teens
    What Do We Do About Dyslexia?
    Oral Contraceptive Users and Depressive Symptoms
    Vitamin D for ADHD?
    Which Medications Have the Lowest Risk of Side Effects?
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2432683359.jpg
      Child Psychiatry

      Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention

      The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. Stay with us as we talk about the...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.